| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fallopian Tube Neoplasms | 50 | 2024 | 329 | 11.960 |
Why?
|
| Cystadenocarcinoma, Serous | 44 | 2024 | 475 | 9.380 |
Why?
|
| Papillomaviridae | 136 | 2023 | 1117 | 7.960 |
Why?
|
| Uterine Cervical Neoplasms | 139 | 2023 | 2018 | 7.110 |
Why?
|
| Carcinoma in Situ | 53 | 2022 | 796 | 6.200 |
Why?
|
| Uterine Cervical Dysplasia | 58 | 2015 | 387 | 5.990 |
Why?
|
| Ovarian Neoplasms | 78 | 2024 | 4875 | 4.970 |
Why?
|
| Tumor Virus Infections | 70 | 2008 | 438 | 4.600 |
Why?
|
| Precancerous Conditions | 53 | 2021 | 978 | 4.350 |
Why?
|
| Vulvar Neoplasms | 36 | 2020 | 265 | 3.930 |
Why?
|
| Fallopian Tubes | 25 | 2023 | 178 | 3.790 |
Why?
|
| Papillomavirus Infections | 60 | 2023 | 1600 | 3.470 |
Why?
|
| Pelvic Neoplasms | 11 | 2013 | 248 | 2.660 |
Why?
|
| Tumor Suppressor Protein p53 | 37 | 2020 | 2927 | 1.860 |
Why?
|
| Carcinoma | 21 | 2022 | 2334 | 1.780 |
Why?
|
| Cervix Uteri | 35 | 2017 | 585 | 1.740 |
Why?
|
| Carcinoma, Squamous Cell | 45 | 2019 | 4024 | 1.730 |
Why?
|
| Peritoneal Neoplasms | 11 | 2024 | 706 | 1.690 |
Why?
|
| Genes, BRCA1 | 21 | 2013 | 769 | 1.690 |
Why?
|
| Carcinoma, Endometrioid | 8 | 2020 | 276 | 1.680 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 18 | 2019 | 698 | 1.660 |
Why?
|
| Uterine Cervical Diseases | 18 | 2020 | 74 | 1.570 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 6 | 2020 | 194 | 1.500 |
Why?
|
| Genes, BRCA2 | 19 | 2013 | 604 | 1.470 |
Why?
|
| DNA, Viral | 55 | 2016 | 2195 | 1.440 |
Why?
|
| Condylomata Acuminata | 26 | 1998 | 75 | 1.390 |
Why?
|
| PAX2 Transcription Factor | 8 | 2014 | 86 | 1.340 |
Why?
|
| Cell Transformation, Neoplastic | 25 | 2015 | 2823 | 1.330 |
Why?
|
| Ki-67 Antigen | 23 | 2019 | 631 | 1.300 |
Why?
|
| Genital Neoplasms, Female | 16 | 2024 | 538 | 1.260 |
Why?
|
| Immunohistochemistry | 50 | 2024 | 11064 | 1.180 |
Why?
|
| Vaginal Smears | 22 | 2008 | 495 | 1.140 |
Why?
|
| Epithelial Cells | 15 | 2023 | 3665 | 1.110 |
Why?
|
| Genes, p53 | 13 | 2018 | 714 | 1.100 |
Why?
|
| Neoplasms, Squamous Cell | 6 | 2014 | 95 | 1.100 |
Why?
|
| Female | 352 | 2024 | 391011 | 0.940 |
Why?
|
| Endometrial Neoplasms | 16 | 2019 | 1361 | 0.920 |
Why?
|
| Endometrium | 13 | 2021 | 403 | 0.920 |
Why?
|
| Neoplastic Stem Cells | 6 | 2018 | 1347 | 0.910 |
Why?
|
| Polyploidy | 2 | 2024 | 119 | 0.910 |
Why?
|
| Polymerase Chain Reaction | 26 | 2010 | 6067 | 0.890 |
Why?
|
| Neoplasms, Glandular and Epithelial | 6 | 2018 | 487 | 0.840 |
Why?
|
| Uterine Neoplasms | 20 | 2020 | 1434 | 0.800 |
Why?
|
| Anus Neoplasms | 4 | 2019 | 329 | 0.760 |
Why?
|
| Phosphoproteins | 10 | 2014 | 2441 | 0.750 |
Why?
|
| Trans-Activators | 11 | 2014 | 2861 | 0.750 |
Why?
|
| Genital Diseases, Female | 7 | 2015 | 191 | 0.720 |
Why?
|
| Human papillomavirus 6 | 2 | 2019 | 16 | 0.710 |
Why?
|
| Metaplasia | 18 | 2020 | 320 | 0.680 |
Why?
|
| Humans | 375 | 2024 | 760261 | 0.680 |
Why?
|
| Human papillomavirus 16 | 6 | 2019 | 266 | 0.670 |
Why?
|
| Mutation | 40 | 2019 | 29950 | 0.660 |
Why?
|
| Vulvar Diseases | 5 | 2021 | 62 | 0.660 |
Why?
|
| Vulva | 6 | 2018 | 82 | 0.640 |
Why?
|
| Endometriosis | 7 | 2021 | 871 | 0.640 |
Why?
|
| Biopsy | 33 | 2021 | 6775 | 0.600 |
Why?
|
| Loss of Heterozygosity | 5 | 2010 | 659 | 0.570 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2018 | 218 | 0.560 |
Why?
|
| Keratin-7 | 1 | 2016 | 55 | 0.550 |
Why?
|
| beta Catenin | 2 | 2020 | 1043 | 0.550 |
Why?
|
| BRCA1 Protein | 7 | 2015 | 1146 | 0.540 |
Why?
|
| BRCA2 Protein | 6 | 2015 | 797 | 0.540 |
Why?
|
| Neoplasm, Residual | 4 | 2014 | 1008 | 0.530 |
Why?
|
| Epithelium | 21 | 2021 | 1605 | 0.530 |
Why?
|
| Cell Lineage | 8 | 2018 | 2525 | 0.520 |
Why?
|
| Neoplasm Recurrence, Local | 13 | 2022 | 9274 | 0.520 |
Why?
|
| Tumor Escape | 1 | 2018 | 371 | 0.520 |
Why?
|
| Adenocarcinoma | 19 | 2023 | 6310 | 0.510 |
Why?
|
| Mucous Membrane | 4 | 2017 | 657 | 0.500 |
Why?
|
| Ovarian Cysts | 2 | 2020 | 107 | 0.480 |
Why?
|
| Viral Vaccines | 3 | 2006 | 598 | 0.480 |
Why?
|
| Ovary | 9 | 2019 | 959 | 0.470 |
Why?
|
| Oncogene Proteins, Viral | 11 | 2015 | 341 | 0.450 |
Why?
|
| Neoplasms, Multiple Primary | 7 | 2010 | 586 | 0.450 |
Why?
|
| Mass Screening | 10 | 2012 | 5422 | 0.440 |
Why?
|
| Immunoenzyme Techniques | 21 | 2014 | 1705 | 0.430 |
Why?
|
| CA-125 Antigen | 3 | 2012 | 280 | 0.430 |
Why?
|
| In Situ Hybridization | 16 | 2015 | 1900 | 0.430 |
Why?
|
| Stem Cells | 12 | 2023 | 3525 | 0.430 |
Why?
|
| Early Detection of Cancer | 4 | 2017 | 3215 | 0.420 |
Why?
|
| Nucleic Acid Hybridization | 20 | 2010 | 1304 | 0.410 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 896 | 0.410 |
Why?
|
| Barrett Esophagus | 6 | 2019 | 490 | 0.400 |
Why?
|
| Cyclin E | 5 | 2007 | 157 | 0.390 |
Why?
|
| Peritoneum | 4 | 2020 | 225 | 0.390 |
Why?
|
| Ovariectomy | 8 | 2013 | 611 | 0.380 |
Why?
|
| Observer Variation | 14 | 2021 | 2596 | 0.380 |
Why?
|
| Endometrial Hyperplasia | 4 | 2010 | 98 | 0.380 |
Why?
|
| Tumor Suppressor Proteins | 9 | 2020 | 2804 | 0.370 |
Why?
|
| Genes, Tumor Suppressor | 6 | 2008 | 1056 | 0.370 |
Why?
|
| Cell Proliferation | 12 | 2020 | 10434 | 0.360 |
Why?
|
| Adnexa Uteri | 2 | 2019 | 40 | 0.350 |
Why?
|
| Adult | 111 | 2024 | 219847 | 0.350 |
Why?
|
| Carbonic Anhydrases | 3 | 2001 | 109 | 0.340 |
Why?
|
| Oropharynx | 1 | 2010 | 132 | 0.340 |
Why?
|
| Membrane Proteins | 10 | 2013 | 7854 | 0.330 |
Why?
|
| Diethylstilbestrol | 2 | 2008 | 88 | 0.330 |
Why?
|
| Antigens, Neoplasm | 7 | 2008 | 1999 | 0.330 |
Why?
|
| Hysterectomy | 9 | 2014 | 901 | 0.320 |
Why?
|
| Lichen Sclerosus et Atrophicus | 2 | 2000 | 28 | 0.320 |
Why?
|
| Middle Aged | 88 | 2024 | 220175 | 0.320 |
Why?
|
| Papillomavirus Vaccines | 2 | 2006 | 486 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 16 | 2020 | 8498 | 0.310 |
Why?
|
| DNA, Neoplasm | 15 | 2010 | 1745 | 0.310 |
Why?
|
| Immunophenotyping | 7 | 2014 | 1870 | 0.300 |
Why?
|
| Predictive Value of Tests | 19 | 2024 | 15273 | 0.300 |
Why?
|
| Uterine Diseases | 3 | 2003 | 117 | 0.300 |
Why?
|
| Diagnosis, Differential | 26 | 2024 | 12968 | 0.290 |
Why?
|
| Mucins | 3 | 2000 | 568 | 0.290 |
Why?
|
| Disease Progression | 11 | 2016 | 13505 | 0.290 |
Why?
|
| Neoplasm Proteins | 9 | 2020 | 3613 | 0.280 |
Why?
|
| Placenta | 8 | 2014 | 1701 | 0.280 |
Why?
|
| Urologic Diseases | 1 | 2008 | 247 | 0.260 |
Why?
|
| Nuclear Proteins | 9 | 2024 | 5793 | 0.260 |
Why?
|
| Adenocarcinoma, Mucinous | 3 | 2013 | 517 | 0.260 |
Why?
|
| Carcinoma, Adenosquamous | 3 | 2001 | 66 | 0.260 |
Why?
|
| PTEN Phosphohydrolase | 6 | 2013 | 1115 | 0.250 |
Why?
|
| Trophoblasts | 4 | 2014 | 224 | 0.250 |
Why?
|
| Endocrine Disruptors | 1 | 2008 | 263 | 0.250 |
Why?
|
| Aged | 64 | 2024 | 168995 | 0.250 |
Why?
|
| DNA Probes, HPV | 8 | 2005 | 21 | 0.250 |
Why?
|
| Cell Differentiation | 17 | 2020 | 11480 | 0.240 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 370 | 0.240 |
Why?
|
| Vaginal Diseases | 2 | 2020 | 103 | 0.240 |
Why?
|
| Chlamydia Infections | 5 | 1987 | 362 | 0.240 |
Why?
|
| Embryonic and Fetal Development | 2 | 2002 | 420 | 0.240 |
Why?
|
| Acanthosis Nigricans | 1 | 2004 | 47 | 0.240 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2010 | 491 | 0.240 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2020 | 3618 | 0.240 |
Why?
|
| Carcinoma, Verrucous | 1 | 2004 | 27 | 0.230 |
Why?
|
| DNA-Binding Proteins | 14 | 2020 | 9590 | 0.230 |
Why?
|
| Stathmin | 2 | 2015 | 70 | 0.230 |
Why?
|
| Uterus | 3 | 2022 | 651 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2018 | 17766 | 0.230 |
Why?
|
| Trophoblastic Neoplasms | 3 | 2015 | 88 | 0.220 |
Why?
|
| Vaccines, Synthetic | 1 | 2006 | 617 | 0.220 |
Why?
|
| Bowen's Disease | 3 | 1996 | 13 | 0.220 |
Why?
|
| DNA Mutational Analysis | 10 | 2019 | 4109 | 0.220 |
Why?
|
| Neoplasms, Second Primary | 2 | 2007 | 1060 | 0.220 |
Why?
|
| Keratosis, Seborrheic | 1 | 2003 | 27 | 0.220 |
Why?
|
| Microsatellite Repeats | 3 | 2000 | 786 | 0.220 |
Why?
|
| Vaginal Neoplasms | 4 | 2020 | 105 | 0.210 |
Why?
|
| Hydatidiform Mole | 5 | 2014 | 255 | 0.210 |
Why?
|
| Adnexal Diseases | 2 | 2024 | 104 | 0.210 |
Why?
|
| Herpes Simplex Virus Vaccines | 1 | 2002 | 18 | 0.210 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2024 | 210 | 0.210 |
Why?
|
| Aged, 80 and over | 26 | 2024 | 58947 | 0.210 |
Why?
|
| Urogenital System | 1 | 2002 | 88 | 0.210 |
Why?
|
| RNA, Viral | 8 | 2015 | 2837 | 0.210 |
Why?
|
| Herpes Genitalis | 2 | 2002 | 142 | 0.200 |
Why?
|
| Pathology, Surgical | 1 | 2003 | 151 | 0.200 |
Why?
|
| Disease Management | 1 | 2013 | 2508 | 0.200 |
Why?
|
| Germ Cells | 2 | 2010 | 635 | 0.200 |
Why?
|
| Peritoneal Cavity | 1 | 2022 | 142 | 0.200 |
Why?
|
| Peritoneal Diseases | 2 | 2021 | 76 | 0.200 |
Why?
|
| Esophagus | 4 | 2019 | 1023 | 0.200 |
Why?
|
| Colposcopy | 9 | 2002 | 150 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2024 | 3774 | 0.200 |
Why?
|
| Catheter Ablation | 1 | 2015 | 2755 | 0.200 |
Why?
|
| Polymorphism, Restriction Fragment Length | 8 | 2003 | 761 | 0.190 |
Why?
|
| Hyperplasia | 7 | 2009 | 1158 | 0.190 |
Why?
|
| Gene Expression Profiling | 11 | 2018 | 9388 | 0.190 |
Why?
|
| RNA, Neoplasm | 4 | 2020 | 749 | 0.190 |
Why?
|
| Telomerase | 2 | 2004 | 747 | 0.190 |
Why?
|
| Herpesvirus 2, Human | 1 | 2002 | 190 | 0.190 |
Why?
|
| Cell Nucleus | 10 | 2010 | 2909 | 0.190 |
Why?
|
| Sensitivity and Specificity | 13 | 2024 | 14656 | 0.190 |
Why?
|
| Carcinoma, Neuroendocrine | 3 | 2001 | 346 | 0.190 |
Why?
|
| Cell Transformation, Viral | 7 | 2015 | 526 | 0.180 |
Why?
|
| Mullerian Ducts | 3 | 2018 | 201 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2010 | 276 | 0.170 |
Why?
|
| Anal Canal | 3 | 2017 | 373 | 0.170 |
Why?
|
| Microdissection | 3 | 2010 | 151 | 0.170 |
Why?
|
| Adenofibroma | 2 | 2010 | 25 | 0.170 |
Why?
|
| Alphapapillomavirus | 2 | 2013 | 218 | 0.170 |
Why?
|
| Reproducibility of Results | 12 | 2015 | 20048 | 0.170 |
Why?
|
| RNA Helicases | 1 | 2000 | 146 | 0.170 |
Why?
|
| Neurodermatitis | 1 | 2019 | 8 | 0.170 |
Why?
|
| Staining and Labeling | 5 | 2007 | 1090 | 0.170 |
Why?
|
| Transcription Factors | 14 | 2024 | 12100 | 0.160 |
Why?
|
| Sarcoma, Synovial | 1 | 2020 | 151 | 0.160 |
Why?
|
| Prognosis | 18 | 2020 | 29636 | 0.160 |
Why?
|
| Tobacco Mosaic Virus | 2 | 1988 | 16 | 0.160 |
Why?
|
| Gene Rearrangement | 2 | 2024 | 1122 | 0.160 |
Why?
|
| Penile Neoplasms | 3 | 1990 | 162 | 0.160 |
Why?
|
| Choristoma | 1 | 2020 | 207 | 0.160 |
Why?
|
| Mice | 28 | 2023 | 81216 | 0.160 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2018 | 22 | 0.150 |
Why?
|
| Antigens, Viral | 11 | 2003 | 980 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2020 | 3023 | 0.150 |
Why?
|
| Papillomavirus E7 Proteins | 5 | 2011 | 111 | 0.150 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 113 | 0.150 |
Why?
|
| Endometritis | 4 | 1987 | 49 | 0.150 |
Why?
|
| Adult Stem Cells | 1 | 2020 | 221 | 0.150 |
Why?
|
| Cell Cycle | 3 | 2001 | 2937 | 0.150 |
Why?
|
| Esophageal Neoplasms | 5 | 2019 | 1651 | 0.150 |
Why?
|
| Electrosurgery | 3 | 2014 | 52 | 0.150 |
Why?
|
| Phenotype | 13 | 2018 | 16543 | 0.140 |
Why?
|
| Leiomyosarcoma | 3 | 2012 | 424 | 0.140 |
Why?
|
| Chorionic Villi | 3 | 2010 | 53 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 499 | 0.140 |
Why?
|
| Animals | 47 | 2023 | 167940 | 0.140 |
Why?
|
| Embryonic Stem Cells | 3 | 2013 | 1262 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 11 | 2018 | 3618 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 3223 | 0.140 |
Why?
|
| DNA Damage | 6 | 2010 | 2442 | 0.140 |
Why?
|
| Vulvodynia | 1 | 2016 | 7 | 0.140 |
Why?
|
| Placenta Diseases | 2 | 2010 | 196 | 0.140 |
Why?
|
| Uterine Cervicitis | 3 | 1987 | 31 | 0.140 |
Why?
|
| Lung | 5 | 2023 | 9989 | 0.140 |
Why?
|
| Pregnancy Complications, Neoplastic | 3 | 2013 | 255 | 0.140 |
Why?
|
| Syphilis, Congenital | 1 | 1996 | 25 | 0.140 |
Why?
|
| Serum | 1 | 2017 | 211 | 0.130 |
Why?
|
| Treponema pallidum | 1 | 1996 | 47 | 0.130 |
Why?
|
| Leiomyoma | 2 | 2012 | 654 | 0.130 |
Why?
|
| Rhabdoid Tumor | 1 | 2018 | 210 | 0.130 |
Why?
|
| Adenoma | 2 | 2019 | 2148 | 0.130 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2020 | 867 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 6 | 2024 | 2500 | 0.130 |
Why?
|
| Tissue Banks | 1 | 2016 | 185 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 8945 | 0.130 |
Why?
|
| DNA Primers | 5 | 2003 | 2819 | 0.120 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2018 | 306 | 0.120 |
Why?
|
| Early Diagnosis | 3 | 2012 | 1181 | 0.120 |
Why?
|
| Keratin-5 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Organoids | 2 | 2018 | 729 | 0.120 |
Why?
|
| DNA | 4 | 2004 | 7236 | 0.120 |
Why?
|
| Salpingectomy | 1 | 2015 | 48 | 0.120 |
Why?
|
| Homosexuality, Female | 1 | 1996 | 159 | 0.120 |
Why?
|
| Abortion, Spontaneous | 2 | 2001 | 530 | 0.120 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2000 | 559 | 0.120 |
Why?
|
| Germ-Line Mutation | 3 | 2013 | 1843 | 0.120 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2017 | 243 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2023 | 1274 | 0.120 |
Why?
|
| Spectrometry, Fluorescence | 5 | 2009 | 686 | 0.110 |
Why?
|
| Terminology as Topic | 4 | 2018 | 1534 | 0.110 |
Why?
|
| Risk Factors | 21 | 2020 | 74269 | 0.110 |
Why?
|
| Disease-Free Survival | 5 | 2019 | 6830 | 0.110 |
Why?
|
| Ribosomal Protein S6 | 1 | 2013 | 71 | 0.110 |
Why?
|
| Genes, ras | 2 | 2007 | 654 | 0.110 |
Why?
|
| Genes, Wilms Tumor | 1 | 1993 | 92 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2013 | 161 | 0.110 |
Why?
|
| Mesothelioma | 3 | 2018 | 806 | 0.110 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2012 | 55 | 0.110 |
Why?
|
| Genes, myc | 1 | 1994 | 395 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2020 | 3784 | 0.100 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2017 | 380 | 0.100 |
Why?
|
| Pulmonary Alveoli | 2 | 2014 | 653 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2018 | 854 | 0.100 |
Why?
|
| Neoplasm Seeding | 1 | 2012 | 85 | 0.100 |
Why?
|
| Warts | 5 | 1984 | 66 | 0.100 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2013 | 169 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1663 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2013 | 1890 | 0.100 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 1388 | 0.100 |
Why?
|
| Histocytochemistry | 6 | 2016 | 693 | 0.100 |
Why?
|
| Mitosis | 8 | 2008 | 1193 | 0.100 |
Why?
|
| Prostate | 1 | 2020 | 1793 | 0.100 |
Why?
|
| Pathology | 2 | 2008 | 270 | 0.100 |
Why?
|
| Pregnancy | 19 | 2015 | 29725 | 0.100 |
Why?
|
| Neoplasm Staging | 11 | 2015 | 11141 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2014 | 448 | 0.100 |
Why?
|
| Antiviral Agents | 1 | 2004 | 3061 | 0.100 |
Why?
|
| Stillbirth | 3 | 2010 | 365 | 0.100 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2009 | 223 | 0.090 |
Why?
|
| Umbilical Cord | 2 | 2009 | 181 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2019 | 6545 | 0.090 |
Why?
|
| Keratin-14 | 2 | 2001 | 56 | 0.090 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 3466 | 0.090 |
Why?
|
| DNA Replication | 3 | 2018 | 1412 | 0.090 |
Why?
|
| DNA, Bacterial | 1 | 1996 | 1455 | 0.090 |
Why?
|
| Models, Biological | 4 | 2015 | 9468 | 0.090 |
Why?
|
| Immunologic Tests | 1 | 1991 | 103 | 0.090 |
Why?
|
| Genitalia, Female | 2 | 1990 | 147 | 0.090 |
Why?
|
| Epigenesis, Genetic | 3 | 2015 | 3758 | 0.090 |
Why?
|
| Keratins | 3 | 2001 | 497 | 0.090 |
Why?
|
| Genomics | 3 | 2022 | 5790 | 0.090 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2009 | 709 | 0.090 |
Why?
|
| Risk Assessment | 8 | 2013 | 24086 | 0.090 |
Why?
|
| Wilms Tumor | 1 | 1993 | 376 | 0.090 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2010 | 119 | 0.090 |
Why?
|
| Fetus | 5 | 2015 | 1859 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 2023 | 4172 | 0.090 |
Why?
|
| Prevalence | 6 | 2023 | 15687 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 7 | 2020 | 6131 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1729 | 0.090 |
Why?
|
| Genes, p16 | 1 | 2010 | 159 | 0.090 |
Why?
|
| Epididymal Secretory Proteins | 2 | 2010 | 12 | 0.090 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2011 | 174 | 0.090 |
Why?
|
| Retrospective Studies | 15 | 2024 | 80301 | 0.090 |
Why?
|
| Vulvovaginitis | 1 | 1989 | 14 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 2 | 2010 | 513 | 0.080 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1993 | 329 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2010 | 426 | 0.080 |
Why?
|
| Polyps | 2 | 2009 | 197 | 0.080 |
Why?
|
| Langerhans Cells | 1 | 2010 | 171 | 0.080 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2010 | 285 | 0.080 |
Why?
|
| Centrosome | 2 | 2001 | 207 | 0.080 |
Why?
|
| Skin | 4 | 2008 | 4468 | 0.080 |
Why?
|
| Salpingitis | 2 | 1987 | 11 | 0.080 |
Why?
|
| Base Sequence | 9 | 2008 | 12447 | 0.080 |
Why?
|
| Carcinoma, Papillary | 2 | 2007 | 785 | 0.080 |
Why?
|
| Contraception | 1 | 1992 | 348 | 0.080 |
Why?
|
| DNA Repair | 1 | 2018 | 2039 | 0.080 |
Why?
|
| Clone Cells | 3 | 2018 | 1663 | 0.080 |
Why?
|
| Acetates | 2 | 1990 | 322 | 0.080 |
Why?
|
| Wolffian Ducts | 2 | 2019 | 27 | 0.080 |
Why?
|
| Penis | 1 | 1990 | 212 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 6226 | 0.080 |
Why?
|
| Mast Cells | 1 | 2016 | 1428 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 1 | 2010 | 333 | 0.080 |
Why?
|
| Molecular Sequence Data | 8 | 2008 | 17628 | 0.080 |
Why?
|
| Oocytes | 2 | 2006 | 1165 | 0.080 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2010 | 117 | 0.080 |
Why?
|
| Boston | 3 | 2017 | 9282 | 0.080 |
Why?
|
| Exons | 2 | 2019 | 2391 | 0.080 |
Why?
|
| Chlamydia | 2 | 1985 | 33 | 0.080 |
Why?
|
| Iron | 1 | 2017 | 1786 | 0.080 |
Why?
|
| Blotting, Southern | 3 | 1996 | 778 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2012 | 7593 | 0.080 |
Why?
|
| DNA Copy Number Variations | 4 | 2019 | 2008 | 0.080 |
Why?
|
| Cystadenoma, Serous | 1 | 2008 | 100 | 0.080 |
Why?
|
| Decidua | 1 | 2008 | 82 | 0.080 |
Why?
|
| Proteomics | 2 | 2023 | 3810 | 0.080 |
Why?
|
| Survival Rate | 4 | 2020 | 12806 | 0.080 |
Why?
|
| Histones | 2 | 2009 | 2583 | 0.080 |
Why?
|
| Adolescent | 20 | 2024 | 87747 | 0.070 |
Why?
|
| Struma Ovarii | 1 | 2007 | 11 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2012 | 5039 | 0.070 |
Why?
|
| Antigens, Nuclear | 2 | 2000 | 184 | 0.070 |
Why?
|
| Obstetric Labor Complications | 1 | 2010 | 236 | 0.070 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2008 | 124 | 0.070 |
Why?
|
| Plant Diseases | 1 | 1988 | 155 | 0.070 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2009 | 286 | 0.070 |
Why?
|
| Carcinoembryonic Antigen | 4 | 2001 | 336 | 0.070 |
Why?
|
| Bronchi | 1 | 2011 | 848 | 0.070 |
Why?
|
| Umbilical Veins | 1 | 2008 | 426 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2010 | 1135 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2024 | 2414 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 2 | 2007 | 416 | 0.070 |
Why?
|
| Cell Line, Tumor | 5 | 2015 | 16905 | 0.070 |
Why?
|
| RNA, Double-Stranded | 1 | 1988 | 295 | 0.070 |
Why?
|
| Gynecology | 1 | 1993 | 534 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1999 | 2127 | 0.070 |
Why?
|
| Ovarian Diseases | 1 | 2008 | 136 | 0.070 |
Why?
|
| Genes, Viral | 5 | 2002 | 650 | 0.070 |
Why?
|
| Radiotherapy Dosage | 2 | 2013 | 2897 | 0.070 |
Why?
|
| DNA Probes | 3 | 2010 | 551 | 0.070 |
Why?
|
| Follow-Up Studies | 10 | 2018 | 39254 | 0.070 |
Why?
|
| Apoptosis | 5 | 2020 | 9497 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2001 | 1955 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1988 | 778 | 0.070 |
Why?
|
| Fetal Death | 1 | 2008 | 434 | 0.070 |
Why?
|
| Conization | 1 | 2005 | 17 | 0.070 |
Why?
|
| Plant Proteins | 1 | 1988 | 370 | 0.070 |
Why?
|
| Disease Models, Animal | 7 | 2013 | 18134 | 0.070 |
Why?
|
| Intestines | 1 | 2015 | 1907 | 0.070 |
Why?
|
| Postmenopause | 1 | 1995 | 2503 | 0.070 |
Why?
|
| Hair Follicle | 1 | 2008 | 211 | 0.070 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2008 | 259 | 0.060 |
Why?
|
| Random Allocation | 1 | 2010 | 2394 | 0.060 |
Why?
|
| Regeneration | 1 | 2014 | 1506 | 0.060 |
Why?
|
| Specimen Handling | 2 | 2009 | 708 | 0.060 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2010 | 612 | 0.060 |
Why?
|
| Spouses | 1 | 2007 | 279 | 0.060 |
Why?
|
| Age Factors | 9 | 2015 | 18415 | 0.060 |
Why?
|
| Young Adult | 9 | 2024 | 58673 | 0.060 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2009 | 493 | 0.060 |
Why?
|
| Meiosis | 1 | 2006 | 327 | 0.060 |
Why?
|
| Fetal Diseases | 1 | 2010 | 911 | 0.060 |
Why?
|
| Cells, Cultured | 8 | 2016 | 18968 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2010 | 1254 | 0.060 |
Why?
|
| Placenta Accreta | 1 | 2008 | 237 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2008 | 1098 | 0.060 |
Why?
|
| Melanocytes | 1 | 2008 | 512 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2010 | 1112 | 0.060 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2024 | 59 | 0.060 |
Why?
|
| Keratinocytes | 3 | 2003 | 792 | 0.060 |
Why?
|
| RNA, Messenger | 7 | 2008 | 12762 | 0.060 |
Why?
|
| Cell Division | 3 | 2000 | 4462 | 0.060 |
Why?
|
| Epithelioid Cells | 1 | 2024 | 60 | 0.060 |
Why?
|
| Incidental Findings | 1 | 2009 | 698 | 0.060 |
Why?
|
| Esophageal Diseases | 1 | 1985 | 168 | 0.060 |
Why?
|
| Cell Cycle Proteins | 3 | 2013 | 3448 | 0.060 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 759 | 0.060 |
Why?
|
| Cell Survival | 2 | 2013 | 5796 | 0.060 |
Why?
|
| Gene Expression | 3 | 2001 | 7592 | 0.060 |
Why?
|
| Membrane Glycoproteins | 3 | 2010 | 3731 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1090 | 0.060 |
Why?
|
| Spectrum Analysis | 2 | 2004 | 453 | 0.060 |
Why?
|
| Treatment Outcome | 10 | 2019 | 64947 | 0.050 |
Why?
|
| Cysts | 2 | 2008 | 683 | 0.050 |
Why?
|
| Virus Integration | 2 | 2013 | 302 | 0.050 |
Why?
|
| Gestational Age | 5 | 2013 | 3564 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 1992 | 2080 | 0.050 |
Why?
|
| Ploidies | 5 | 2010 | 275 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1655 | 0.050 |
Why?
|
| Exocrine Glands | 1 | 2002 | 46 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 1244 | 0.050 |
Why?
|
| HMGA2 Protein | 1 | 2003 | 102 | 0.050 |
Why?
|
| X Chromosome | 2 | 1997 | 815 | 0.050 |
Why?
|
| Clitoris | 1 | 2002 | 35 | 0.050 |
Why?
|
| Antigens, Bacterial | 2 | 1985 | 1155 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11708 | 0.050 |
Why?
|
| Students | 1 | 1992 | 1722 | 0.050 |
Why?
|
| Protein Precursors | 1 | 1987 | 1135 | 0.050 |
Why?
|
| Cell Movement | 3 | 2010 | 5206 | 0.050 |
Why?
|
| Urinary Bladder Fistula | 1 | 1982 | 9 | 0.050 |
Why?
|
| Reference Values | 4 | 2004 | 4920 | 0.050 |
Why?
|
| Vaccination | 2 | 2006 | 3360 | 0.050 |
Why?
|
| Pregnancy Outcome | 2 | 2010 | 2906 | 0.050 |
Why?
|
| Case-Control Studies | 5 | 2016 | 22041 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2010 | 4002 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2005 | 2363 | 0.050 |
Why?
|
| Gene Dosage | 2 | 2016 | 1218 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3696 | 0.050 |
Why?
|
| Male | 32 | 2020 | 359413 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 1740 | 0.050 |
Why?
|
| Artifacts | 1 | 2010 | 1893 | 0.050 |
Why?
|
| Myofibroblasts | 1 | 2023 | 207 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2004 | 629 | 0.050 |
Why?
|
| Protein Kinases | 1 | 1988 | 1612 | 0.050 |
Why?
|
| Thrombosis | 3 | 2010 | 3052 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2010 | 2119 | 0.050 |
Why?
|
| Contraceptives, Oral | 1 | 2003 | 554 | 0.050 |
Why?
|
| Herpesviridae Infections | 1 | 1982 | 270 | 0.050 |
Why?
|
| NADP | 1 | 2002 | 223 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 414 | 0.050 |
Why?
|
| Mucin-2 | 1 | 2000 | 50 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 1988 | 2104 | 0.050 |
Why?
|
| Atrophy | 2 | 2008 | 1625 | 0.050 |
Why?
|
| Gene Products, env | 1 | 2001 | 250 | 0.050 |
Why?
|
| Cryptococcosis | 1 | 1981 | 103 | 0.050 |
Why?
|
| Genome, Human | 1 | 2013 | 4416 | 0.050 |
Why?
|
| Cryosurgery | 2 | 1985 | 473 | 0.050 |
Why?
|
| Pregnancy Proteins | 1 | 2001 | 222 | 0.050 |
Why?
|
| Carcinoma, Large Cell | 1 | 2001 | 113 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 2 | 2004 | 1602 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2023 | 446 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 1186 | 0.040 |
Why?
|
| Mucin 5AC | 1 | 2000 | 97 | 0.040 |
Why?
|
| Gonads | 1 | 2000 | 109 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2007 | 2608 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 4409 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 1 | 2000 | 182 | 0.040 |
Why?
|
| Skin Neoplasms | 4 | 2003 | 5797 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2020 | 46 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2020 | 42 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2011 | 1532 | 0.040 |
Why?
|
| Plasma Cells | 1 | 1983 | 592 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2020 | 40 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2001 | 283 | 0.040 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 1985 | 464 | 0.040 |
Why?
|
| Capsid Proteins | 2 | 2015 | 467 | 0.040 |
Why?
|
| Fistula | 1 | 1982 | 214 | 0.040 |
Why?
|
| Immunologic Techniques | 2 | 1990 | 213 | 0.040 |
Why?
|
| Neoplasms | 3 | 2010 | 22066 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1577 | 0.040 |
Why?
|
| WT1 Proteins | 2 | 2007 | 184 | 0.040 |
Why?
|
| Combined Modality Therapy | 4 | 2006 | 8551 | 0.040 |
Why?
|
| Oncogene Fusion | 1 | 2020 | 81 | 0.040 |
Why?
|
| Risk | 3 | 2010 | 9629 | 0.040 |
Why?
|
| Genomic Imprinting | 1 | 2001 | 330 | 0.040 |
Why?
|
| Meningitis | 1 | 1981 | 218 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1617 | 0.040 |
Why?
|
| Phosphorylation | 4 | 2013 | 8314 | 0.040 |
Why?
|
| Forelimb | 1 | 1999 | 115 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 13249 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2000 | 385 | 0.040 |
Why?
|
| Peritonitis | 1 | 1981 | 370 | 0.040 |
Why?
|
| Quality Control | 2 | 2008 | 827 | 0.040 |
Why?
|
| Cerebral Ventricles | 1 | 1981 | 543 | 0.040 |
Why?
|
| Polyomaviridae | 1 | 1998 | 9 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2016 | 729 | 0.040 |
Why?
|
| Consensus | 1 | 2008 | 3106 | 0.040 |
Why?
|
| Genital Neoplasms, Male | 1 | 1998 | 68 | 0.040 |
Why?
|
| Plasmids | 3 | 2003 | 2277 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2020 | 1085 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2010 | 3605 | 0.040 |
Why?
|
| Online Systems | 1 | 2019 | 181 | 0.040 |
Why?
|
| Omentum | 1 | 2019 | 169 | 0.040 |
Why?
|
| Time Factors | 6 | 2018 | 40133 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2006 | 10340 | 0.040 |
Why?
|
| Diagnostic Errors | 2 | 2003 | 1266 | 0.040 |
Why?
|
| beta-Defensins | 2 | 2010 | 59 | 0.040 |
Why?
|
| Sulfur Radioisotopes | 2 | 1988 | 113 | 0.040 |
Why?
|
| Referral and Consultation | 2 | 2008 | 3598 | 0.040 |
Why?
|
| Osteosarcoma | 2 | 2001 | 898 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2007 | 2052 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2000 | 383 | 0.040 |
Why?
|
| Proteins | 1 | 2012 | 6030 | 0.040 |
Why?
|
| Protoporphyrins | 1 | 1997 | 165 | 0.040 |
Why?
|
| Child | 5 | 2024 | 79758 | 0.040 |
Why?
|
| Dilatation, Pathologic | 2 | 2009 | 527 | 0.040 |
Why?
|
| Immunotherapy | 2 | 2003 | 4637 | 0.040 |
Why?
|
| Menstrual Cycle | 1 | 2001 | 536 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1792 | 0.040 |
Why?
|
| Intestine, Small | 2 | 2015 | 1207 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2003 | 3605 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6855 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2002 | 2671 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 454 | 0.040 |
Why?
|
| Transsexualism | 1 | 2020 | 177 | 0.040 |
Why?
|
| Chromosomes, Human | 1 | 1999 | 442 | 0.040 |
Why?
|
| Hindlimb | 1 | 1999 | 510 | 0.040 |
Why?
|
| Aminolevulinic Acid | 1 | 1997 | 142 | 0.030 |
Why?
|
| Introns | 1 | 2019 | 978 | 0.030 |
Why?
|
| Inflammation | 3 | 2023 | 10757 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 1978 | 308 | 0.030 |
Why?
|
| Societies, Medical | 2 | 2019 | 3903 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2006 | 6361 | 0.030 |
Why?
|
| Vagina | 2 | 1995 | 842 | 0.030 |
Why?
|
| Hematoxylin | 1 | 1996 | 60 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 1993 | 4312 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 9531 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 796 | 0.030 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 1996 | 26 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 2940 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2178 | 0.030 |
Why?
|
| Mycosis Fungoides | 1 | 1977 | 167 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1986 | 217 | 0.030 |
Why?
|
| Fetal Growth Retardation | 2 | 2010 | 579 | 0.030 |
Why?
|
| Pneumonia | 2 | 2020 | 2138 | 0.030 |
Why?
|
| Genotype | 3 | 2023 | 12959 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 679 | 0.030 |
Why?
|
| Taiwan | 1 | 1997 | 503 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 580 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 8984 | 0.030 |
Why?
|
| Open Reading Frames | 3 | 1994 | 814 | 0.030 |
Why?
|
| Carboplatin | 1 | 2018 | 789 | 0.030 |
Why?
|
| Viral Proteins | 3 | 2004 | 1802 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 1078 | 0.030 |
Why?
|
| Bronchioles | 1 | 2014 | 30 | 0.030 |
Why?
|
| Hong Kong | 1 | 2015 | 161 | 0.030 |
Why?
|
| Cell Biology | 1 | 1995 | 90 | 0.030 |
Why?
|
| Viral Load | 1 | 2004 | 3323 | 0.030 |
Why?
|
| Histological Techniques | 2 | 2005 | 194 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2001 | 1739 | 0.030 |
Why?
|
| Pregnancy, Multiple | 1 | 1995 | 215 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2008 | 1518 | 0.030 |
Why?
|
| Body Patterning | 1 | 1999 | 630 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2006 | 13456 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2020 | 756 | 0.030 |
Why?
|
| Y Chromosome | 1 | 1995 | 205 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 3 | 1982 | 457 | 0.030 |
Why?
|
| Skull | 1 | 1999 | 815 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1992 | 3735 | 0.030 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2013 | 42 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1408 | 0.030 |
Why?
|
| Simplexvirus | 3 | 1982 | 803 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2018 | 872 | 0.030 |
Why?
|
| Sarcoma | 2 | 1984 | 1786 | 0.030 |
Why?
|
| Biological Products | 1 | 2003 | 914 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 2 | 1992 | 628 | 0.030 |
Why?
|
| Cisplatin | 2 | 2015 | 1642 | 0.030 |
Why?
|
| Vulvar Lichen Sclerosus | 1 | 2013 | 11 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2013 | 5873 | 0.030 |
Why?
|
| Choriocarcinoma | 1 | 2014 | 121 | 0.030 |
Why?
|
| Collagen | 1 | 2002 | 2635 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1996 | 582 | 0.030 |
Why?
|
| Coloring Agents | 1 | 1996 | 561 | 0.030 |
Why?
|
| Human papillomavirus 11 | 1 | 2013 | 14 | 0.030 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 123 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2007 | 2880 | 0.030 |
Why?
|
| Photosensitizing Agents | 1 | 1997 | 616 | 0.030 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2015 | 265 | 0.030 |
Why?
|
| Culture Media | 1 | 2015 | 899 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 1 | 2013 | 207 | 0.030 |
Why?
|
| Oviducts | 1 | 2012 | 11 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2004 | 12412 | 0.030 |
Why?
|
| Virginia | 1 | 1992 | 116 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 2042 | 0.030 |
Why?
|
| Cell Separation | 1 | 2018 | 1720 | 0.030 |
Why?
|
| Androgens | 1 | 2020 | 1289 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2013 | 311 | 0.030 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2013 | 62 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 857 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 717 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2023 | 4091 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1994 | 392 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 191 | 0.030 |
Why?
|
| Pyrazines | 1 | 2018 | 1200 | 0.030 |
Why?
|
| Tumor Microenvironment | 2 | 2018 | 3826 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 1978 | 736 | 0.030 |
Why?
|
| HLA-B Antigens | 1 | 2013 | 331 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2013 | 871 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2004 | 3491 | 0.030 |
Why?
|
| Acetic Acid | 2 | 1990 | 60 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3584 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2016 | 1600 | 0.030 |
Why?
|
| Laser Therapy | 3 | 1985 | 1089 | 0.030 |
Why?
|
| Antibodies | 1 | 2000 | 2424 | 0.030 |
Why?
|
| F-Box Proteins | 1 | 2013 | 202 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 478 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2000 | 3601 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2001 | 1230 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 250 | 0.020 |
Why?
|
| New England | 1 | 2015 | 1045 | 0.020 |
Why?
|
| Virus Latency | 1 | 1995 | 362 | 0.020 |
Why?
|
| Reproductive History | 1 | 2013 | 210 | 0.020 |
Why?
|
| Laminin | 1 | 2013 | 405 | 0.020 |
Why?
|
| Spectrophotometry | 2 | 1989 | 311 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2204 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1993 | 1544 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7468 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 428 | 0.020 |
Why?
|
| Integrases | 1 | 2013 | 516 | 0.020 |
Why?
|
| ROC Curve | 2 | 2010 | 3568 | 0.020 |
Why?
|
| Virus Replication | 2 | 1990 | 2431 | 0.020 |
Why?
|
| Photochemotherapy | 1 | 1997 | 819 | 0.020 |
Why?
|
| Scattering, Radiation | 2 | 2004 | 488 | 0.020 |
Why?
|
| Microscopy | 1 | 2016 | 881 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2015 | 704 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 376 | 0.020 |
Why?
|
| Tissue Embedding | 1 | 2010 | 42 | 0.020 |
Why?
|
| Methionine | 1 | 2013 | 569 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3726 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 5784 | 0.020 |
Why?
|
| Phthalazines | 1 | 2013 | 377 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 452 | 0.020 |
Why?
|
| Oligohydramnios | 1 | 2010 | 37 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2002 | 14396 | 0.020 |
Why?
|
| Immunoglobulins | 2 | 2010 | 863 | 0.020 |
Why?
|
| Nuchal Cord | 1 | 2009 | 5 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4573 | 0.020 |
Why?
|
| Receptors, Progesterone | 2 | 2008 | 1122 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2013 | 638 | 0.020 |
Why?
|
| Esophagogastric Junction | 1 | 2012 | 341 | 0.020 |
Why?
|
| Transfection | 2 | 2015 | 5782 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2002 | 2277 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2018 | 1591 | 0.020 |
Why?
|
| Serologic Tests | 1 | 1992 | 383 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 284 | 0.020 |
Why?
|
| Dogs | 1 | 2014 | 3843 | 0.020 |
Why?
|
| Computational Biology | 1 | 2001 | 3504 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2010 | 271 | 0.020 |
Why?
|
| Chorion | 1 | 2009 | 114 | 0.020 |
Why?
|
| Apgar Score | 1 | 2009 | 126 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2015 | 931 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2000 | 2978 | 0.020 |
Why?
|
| Testosterone | 1 | 2020 | 2469 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1994 | 1085 | 0.020 |
Why?
|
| Heart Rate, Fetal | 1 | 2009 | 75 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2023 | 42034 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2368 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 600 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 12532 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 13967 | 0.020 |
Why?
|
| Premenopause | 1 | 2013 | 1039 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2010 | 736 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4127 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4717 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 2001 | 11902 | 0.020 |
Why?
|
| Epidermis | 2 | 2003 | 529 | 0.020 |
Why?
|
| MART-1 Antigen | 1 | 2008 | 65 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 1833 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 348 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 1992 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 1134 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2811 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2015 | 1738 | 0.020 |
Why?
|
| Tonsillar Neoplasms | 1 | 2007 | 50 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 1344 | 0.020 |
Why?
|
| Signal Transduction | 4 | 2015 | 23363 | 0.020 |
Why?
|
| Antineoplastic Agents | 3 | 2004 | 13629 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2009 | 378 | 0.020 |
Why?
|
| Dilatation and Curettage | 2 | 1984 | 52 | 0.020 |
Why?
|
| Universities | 1 | 1992 | 983 | 0.020 |
Why?
|
| Neutrophils | 1 | 2020 | 3770 | 0.020 |
Why?
|
| Colon | 1 | 2015 | 1788 | 0.020 |
Why?
|
| Maternal Age | 1 | 2010 | 807 | 0.020 |
Why?
|
| Biotin | 1 | 1988 | 253 | 0.020 |
Why?
|
| Proctitis | 1 | 1987 | 41 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4554 | 0.020 |
Why?
|
| Wound Healing | 2 | 2011 | 2786 | 0.020 |
Why?
|
| Pedigree | 1 | 2014 | 4577 | 0.020 |
Why?
|
| Laparoscopy | 2 | 2010 | 2155 | 0.020 |
Why?
|
| Receptors, Estrogen | 2 | 2008 | 2202 | 0.020 |
Why?
|
| Estrogens | 2 | 2011 | 1520 | 0.020 |
Why?
|
| Inhibins | 1 | 2007 | 209 | 0.020 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1987 | 95 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2846 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 693 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 2186 | 0.020 |
Why?
|
| Oogenesis | 1 | 2006 | 124 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1746 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1601 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1120 | 0.020 |
Why?
|
| Recurrence | 1 | 1998 | 8487 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 1635 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2007 | 225 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1986 | 291 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2017 | 54263 | 0.020 |
Why?
|
| Incidence | 2 | 2018 | 21378 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2805 | 0.020 |
Why?
|
| Immune System | 1 | 1991 | 795 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 1986 | 383 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1977 | 2532 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1548 | 0.020 |
Why?
|
| Chlamydia trachomatis | 1 | 1987 | 238 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 2249 | 0.020 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2009 | 516 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2016 | 41317 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 2668 | 0.010 |
Why?
|
| Immunity | 1 | 1991 | 998 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 1490 | 0.010 |
Why?
|
| Consultants | 1 | 1984 | 53 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 22025 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2008 | 1375 | 0.010 |
Why?
|
| Coitus | 1 | 1984 | 131 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 1549 | 0.010 |
Why?
|
| Digestive System Neoplasms | 1 | 2004 | 81 | 0.010 |
Why?
|
| Optical Fibers | 1 | 2004 | 135 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2058 | 0.010 |
Why?
|
| Rats | 2 | 2011 | 23695 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2013 | 2544 | 0.010 |
Why?
|
| Vacuoles | 1 | 1984 | 229 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3277 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 2003 | 404 | 0.010 |
Why?
|
| Plasminogen | 1 | 2003 | 146 | 0.010 |
Why?
|
| Oxygen | 1 | 2014 | 4189 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 1987 | 432 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9196 | 0.010 |
Why?
|
| Microscopy, Electron | 3 | 1982 | 2558 | 0.010 |
Why?
|
| Cell Communication | 1 | 2010 | 1642 | 0.010 |
Why?
|
| GPI-Linked Proteins | 1 | 2004 | 468 | 0.010 |
Why?
|
| Capsules | 1 | 2003 | 192 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 413 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3804 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2017 | 4374 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2008 | 933 | 0.010 |
Why?
|
| Piperazines | 1 | 2013 | 2520 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12156 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2004 | 553 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1987 | 2473 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2755 | 0.010 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2002 | 121 | 0.010 |
Why?
|
| Receptor, Notch2 | 1 | 2002 | 87 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 614 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2007 | 1246 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 2004 | 289 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2001 | 43 | 0.010 |
Why?
|
| Diffusion | 1 | 2004 | 814 | 0.010 |
Why?
|
| Cervix Mucus | 1 | 1981 | 17 | 0.010 |
Why?
|
| Medical Errors | 1 | 2010 | 1255 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 1634 | 0.010 |
Why?
|
| Protozoan Infections | 1 | 1981 | 38 | 0.010 |
Why?
|
| Sex Offenses | 1 | 1986 | 351 | 0.010 |
Why?
|
| Organoplatinum Compounds | 1 | 2003 | 410 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2893 | 0.010 |
Why?
|
| Aging | 1 | 2000 | 8641 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 4494 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1667 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 1670 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 10829 | 0.010 |
Why?
|
| Mouth | 1 | 2004 | 380 | 0.010 |
Why?
|
| Drugs, Investigational | 1 | 2003 | 214 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 1061 | 0.010 |
Why?
|
| Virion | 1 | 2003 | 421 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2002 | 321 | 0.010 |
Why?
|
| Centrioles | 1 | 2001 | 79 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2007 | 1109 | 0.010 |
Why?
|
| Cesarean Section | 1 | 2009 | 1386 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 1987 | 1470 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2003 | 426 | 0.010 |
Why?
|
| Cryptococcus neoformans | 1 | 1981 | 121 | 0.010 |
Why?
|
| Hematuria | 1 | 1982 | 233 | 0.010 |
Why?
|
| Urothelium | 1 | 2002 | 277 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15766 | 0.010 |
Why?
|
| Necrosis | 1 | 1984 | 1612 | 0.010 |
Why?
|
| Eosinophilia | 1 | 2004 | 560 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 943 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 2178 | 0.010 |
Why?
|
| Taxoids | 1 | 2003 | 668 | 0.010 |
Why?
|
| Mucin-1 | 1 | 2004 | 539 | 0.010 |
Why?
|
| Etoposide | 1 | 2001 | 630 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2002 | 495 | 0.010 |
Why?
|
| Fluorescence | 1 | 2002 | 750 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2002 | 657 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1980 | 222 | 0.010 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 1999 | 62 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 5498 | 0.010 |
Why?
|
| Urinary Tract | 1 | 2002 | 309 | 0.010 |
Why?
|
| Limb Buds | 1 | 1999 | 76 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 1643 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1991 | 1056 | 0.010 |
Why?
|
| Vincristine | 1 | 2001 | 1038 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1985 | 1478 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 2476 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1633 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 136 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1990 | 4223 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 2024 | 0.010 |
Why?
|
| RNA | 1 | 1988 | 2721 | 0.010 |
Why?
|
| Light | 1 | 2004 | 1344 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2262 | 0.010 |
Why?
|
| Cause of Death | 1 | 2008 | 3723 | 0.010 |
Why?
|
| Radiography | 2 | 1978 | 6965 | 0.010 |
Why?
|
| Child Abuse | 1 | 1986 | 1068 | 0.010 |
Why?
|
| Quality of Life | 1 | 2018 | 13300 | 0.010 |
Why?
|
| Craniofacial Abnormalities | 1 | 1999 | 315 | 0.010 |
Why?
|
| Papilloma, Inverted | 1 | 1996 | 19 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2002 | 1166 | 0.010 |
Why?
|
| Sex Determination Analysis | 1 | 1995 | 46 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2004 | 2945 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8157 | 0.010 |
Why?
|
| Giant Cell Arteritis | 1 | 1980 | 296 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12602 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1980 | 701 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4900 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1982 | 721 | 0.010 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2002 | 800 | 0.010 |
Why?
|
| Comorbidity | 1 | 2010 | 10552 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 1997 | 711 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1999 | 740 | 0.010 |
Why?
|
| Brazil | 1 | 1999 | 1214 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 2220 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 7345 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2002 | 2918 | 0.010 |
Why?
|
| Papilloma | 1 | 1996 | 141 | 0.010 |
Why?
|
| Autopsy | 1 | 1978 | 1007 | 0.010 |
Why?
|
| Massachusetts | 1 | 2008 | 8805 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2001 | 2698 | 0.010 |
Why?
|
| Smoking | 1 | 1991 | 9070 | 0.010 |
Why?
|
| Acute Disease | 1 | 1985 | 7268 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1982 | 1415 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2001 | 2207 | 0.010 |
Why?
|
| Decision Making | 1 | 2008 | 3924 | 0.010 |
Why?
|
| Twins | 1 | 1995 | 339 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 1204 | 0.010 |
Why?
|
| Karyotyping | 1 | 1995 | 1172 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2000 | 26168 | 0.010 |
Why?
|
| Nose Neoplasms | 1 | 1996 | 249 | 0.010 |
Why?
|
| Lasers | 3 | 1982 | 952 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 4668 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 1999 | 867 | 0.010 |
Why?
|
| North America | 1 | 1997 | 1282 | 0.010 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1996 | 286 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2825 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2008 | 3421 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2001 | 3531 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 1838 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1978 | 1097 | 0.010 |
Why?
|
| Laryngeal Neoplasms | 1 | 1996 | 514 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2004 | 5120 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 3145 | 0.010 |
Why?
|
| Information Systems | 1 | 1973 | 398 | 0.010 |
Why?
|
| Infant | 1 | 1993 | 36030 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 852 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1997 | 2651 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1983 | 2494 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2008 | 5324 | 0.010 |
Why?
|
| Internet | 1 | 2001 | 3074 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1983 | 9283 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 553 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1991 | 1649 | 0.000 |
Why?
|
| Carbon Dioxide | 2 | 1982 | 1145 | 0.000 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1991 | 789 | 0.000 |
Why?
|
| Crohn Disease | 1 | 1980 | 2275 | 0.000 |
Why?
|
| Genetic Variation | 1 | 2001 | 6540 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 10183 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36247 | 0.000 |
Why?
|
| Actuarial Analysis | 1 | 1984 | 375 | 0.000 |
Why?
|
| Iodine | 1 | 1984 | 286 | 0.000 |
Why?
|
| Capsid | 1 | 1984 | 434 | 0.000 |
Why?
|
| Cautery | 1 | 1981 | 71 | 0.000 |
Why?
|
| Brenner Tumor | 1 | 1981 | 9 | 0.000 |
Why?
|
| Cystadenoma | 1 | 1981 | 79 | 0.000 |
Why?
|
| Desmosomes | 1 | 1980 | 72 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1982 | 941 | 0.000 |
Why?
|
| Aneuploidy | 1 | 1984 | 551 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1982 | 1628 | 0.000 |
Why?
|
| Periodicity | 1 | 1981 | 349 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1981 | 15680 | 0.000 |
Why?
|
| Teratoma | 1 | 1982 | 403 | 0.000 |
Why?
|
| Progesterone | 1 | 1982 | 742 | 0.000 |
Why?
|
| Arteritis | 1 | 1980 | 162 | 0.000 |
Why?
|
| Japan | 1 | 1982 | 1369 | 0.000 |
Why?
|
| Ileum | 1 | 1980 | 556 | 0.000 |
Why?
|
| Cell Line | 1 | 1991 | 15626 | 0.000 |
Why?
|
| Cilia | 1 | 1981 | 492 | 0.000 |
Why?
|
| Epitopes | 1 | 1981 | 2506 | 0.000 |
Why?
|
| Arteries | 1 | 1980 | 1126 | 0.000 |
Why?
|
| Chemistry | 1 | 1973 | 348 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1973 | 508 | 0.000 |
Why?
|
| Data Display | 1 | 1973 | 174 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1980 | 2612 | 0.000 |
Why?
|
| Pain, Postoperative | 1 | 1982 | 1718 | 0.000 |
Why?
|
| Computers | 1 | 1973 | 595 | 0.000 |
Why?
|